FGFR3-mutant uroepithelial carcinoma (UC) exhibits a more immunosuppressive tumor microenvironment (TME) with lower immune cell infiltration and T-cell toxicity compared to FGFR3-wildtype UC. The gene discussed is FGFR3; the disease is urothelial carcinoma.